Women's cancer

Session Chair(s)

• 

  Maria Gonzalez Porras, PhD (she/her/hers)

  Assistant Professor
  University of Texas at San Antonio
  San Antonio, Texas, United States
• 

  Catherine Whittington

  Assistant Professor
  Worcester Polytechnic Institute, United States

Track Chair(s)

• 

  Pilar de la Puente, PhD (she/her/hers)

  Associate Scientist
  Sanford Research / University of South Dakota School of Medicine
  Sioux Falls, South Dakota, United States
• KF

  Kaitlin Fogg, Ph.D. (she/her/hers)

  Assistant Professor
  Oregon State University
  Corvallis, Oregon, United States

Presentations:

• 1:15 PM – 1:30 PM EST

  Physiologically relevant tissue-engineered technologies utilized for precision-based drug screening in women’s cancers as an opportunity to advance women’s health
  

  Presenting Author: Pilar de la Puente, PhD (she/her/hers) – Sanford Research / University of South Dakota School of Medicine
• 1:30 PM – 1:45 PM EST

  3D microphysiological model to evaluate the effects of atovaquone as a therapeutic agent for high-grade serous ovarian carcinoma (HGSOC).
  

  Presenting Author: Paula M. Manan Mejias (she/her/hers) – School of Medicine and Public Health and School of Pharmacy University of Wisconsin Madison,

  Co-Author: Nicha Boonpattrawong – UW SMPH OB-GYN Department

  Primary Investigator: María Virumbrales-Muñoz, MS, PhD (she/her/hers) – UW SMPH OB-GYN Department
• 1:45 PM – 2:00 PM EST

  Evaluating the Degradation of a Novel Form of Ethanol Ablation in a Large Animal Model of the Cervix
  

  Presenting Author: Taya Lee (she/her/hers) – University of Maryland Bioengineering

  Co-Author: Jeffrey Yang (he/him/his) – University of Maryland, College Park

  Co-Author: Michele Kaluzienski – University of Maryland Bioengineering

  Co-Author: Eva S. Landeta (she/her/hers) – University of Maryland Bioengineering

  Co-Author: Brian Crouch – Duke University

  Co-Author: Nirmala Ramanujam, PhD – Duke University

  Primary Investigator: Jenna Mueller, PhD (she/her/hers) – University of Maryland
• 2:00 PM – 2:15 PM EST

  Leveraging Cancer-Associated Mutations to Identify Synthetic Lethal Therapeutic Strategies in Endometriosis
  

  Presenting Author: Asmi Mukherjee (she/her/hers) – Weldon School of Biomedical Engineering, Purdue Univeristy

  Primary Investigator: Douglas Brubaker – Center for Global Health and Diseases, Case Western Reserve University School of Medicine

  Co-Author: Alexis E. Heath (she/her/hers) – Case Western Reserve University

  Co-Author: Nina M. Render (she/her/hers) – Purdue University Weldon School of Biomedical Engineering

  Co-Author: Juan S. Gnecco, PhD (he/him/his) – Tufts University
• 2:15 PM – 2:30 PM EST

  Involvement of Nanoscale Cellular Communication in Obesity-Assisted Breast Cancer Severity
  

  Presenting Author: Tanmoy Saha, PhD (he/him/his) – Brigham and Women's Hoapital, Harvard Medical School
• 2:30 PM – 2:45 PM EST

  Nanoparticle-Based Therapeutics for Targeting Oncogenic Microenvironment in Obesity-Induced Endometrial Cancer
  

  Primary Investigator: Maria Gonzalez Porras, PhD (she/her/hers) – University of Texas at San Antonio

  Presenting Author: David Zhang, MS (he/him/his) – The University of Texas at San Antonio

  Presenting Author: Linda Mota – The University of Texas at San Antonio

  Co-Author: Laura Paredes Cuatin – The University of Texas at San Antonio

  Co-Author: Eric Brey – The University of Texas at San Antonio

  Co-Author: Achraf Noureddine – University of New Mexico

  Co-Author: Nameer Kirma – UT Health San Antonio